Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pilot plant study of alternative filter media for rapid gravity filtration.

Water science and technology : a journal of the International Association on Water Pollution Research·2012
Same author

A centralised electronic Multidrug-Resistant Tuberculosis Advisory Service: the first 2 years.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2012
Same author

Incorporation of an additional glycosylation site enhances expression of functional human gonadotropin-releasing hormone receptor.

Endocrine·2010
Same author

Completeness of notification of adult tuberculosis in Iasi County, Romania: a capture-recapture analysis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2009
Same author

Temporal change in glucose tolerance in non-ST-elevation myocardial infarction.

Diabetes research and clinical practice·2008
Same author

Treatment for mycobacterial infections.

Current opinion in infectious diseases·2006

Related Experiment Video

Updated: Jun 12, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Clinical tuberculosis and treatment outcomes.

T S Jordan1, P D Davies

  • 1Tuberculosis Unit, Liverpool Heart and Chest Hospital, Liverpool, UK. tsjordanhome@yahoo.co.uk

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
|May 22, 2010
PubMed
Summary

Global tuberculosis (TB) control efforts exceeded the 85% treatment success target in 2007. This review examines TB treatment outcomes from articles published in 2009.

Related Experiment Videos

Last Updated: Jun 12, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Area of Science:

  • Public Health
  • Infectious Disease Epidemiology
  • Global Health

Background:

  • The World Health Assembly set global tuberculosis (TB) control targets in 1991, aiming for 70% detection and 85% cure rates for new sputum smear-positive cases.
  • The Directly Observed Treatment, Short-course (DOTS) strategy became central to TB control, underpinning the Stop TB Strategy and its Global Plan (2006-2015).
  • Key goals included achieving the TB-related Millennium Development Goal (MDG) and reducing TB prevalence and mortality by 50% by 2015.

Purpose of the Study:

  • To review articles on tuberculosis treatment outcomes published in the International Journal of Tuberculosis and Lung Disease in 2009.
  • To assess the effectiveness of TB control strategies through treatment success and case detection rates.

Main Methods:

  • Literature review of articles published in 2009.
  • Analysis of outcome indicators such as treatment success and case detection rates.
  • Focus on studies related to tuberculosis treatment outcomes.

Main Results:

  • Globally, the treatment success rate for smear-positive TB cases surpassed the World Health Assembly's target of 85% for the first time in 2007.
  • The review specifically analyzes treatment outcomes reported in 2009.

Conclusions:

  • Global TB control efforts demonstrated progress, exceeding key treatment success benchmarks.
  • Continued monitoring of treatment outcomes is crucial for evaluating and refining TB control strategies.